Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
This blood test measures the amount of beta human chorionic gonadotropin, a hormone produced soon after a fertilized egg attaches to the uterine lining. The test detects and quantifies the hormone in your blood. Unlike a simple yes or no test, a quantitative result shows how much hormone is present.
Beta hCG is most commonly used to help detect and monitor early pregnancy. It can also be measured to follow the course of a pregnancy concern, after a pregnancy event, or in certain medical conditions where small amounts may be present even when you are not pregnant.
Your clinician may order this test to confirm pregnancy, to monitor how a pregnancy is progressing, or to help evaluate symptoms such as bleeding or pain in early pregnancy. Changes in levels over time can provide useful clues alongside your history, exam, and imaging.
Outside of pregnancy, this test may be used to monitor recovery after a pregnancy event or a specific placental condition, and in some cases to help evaluate certain tumors that can produce the hormone. Understanding why the test was ordered in your situation helps guide what results mean and what follow-up is appropriate.
Results are interpreted in context. A single value offers a snapshot, while repeating the test over short intervals shows a trend. Rising levels in early pregnancy are expected, while stable or falling patterns may prompt your clinician to consider other explanations. Your provider may compare the pattern with ultrasound findings to decide next steps.
If you are not pregnant, very low or undetectable levels are typical. Slight detectable results can occur for several reasons, including timing after a recent pregnancy event, certain medications, or rarely from your own pituitary gland or specific tumors. If a result does not fit your situation, your clinician may repeat testing, use a different assay, or order additional tests to clarify the picture.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Very early after conception, levels may be below detection. Testing again after a short interval often clarifies results, especially if the first result is unexpected.
After childbirth, miscarriage, abortion, or treatment of a pregnancy-related condition, levels can take time to return to baseline. Residual hormone may be seen for a period.
Injections used to trigger ovulation contain the same hormone and can cause a temporary positive result. Tell your clinician about any fertility drugs or supplements.
Rare antibodies in your blood, high-dose biotin supplements, or very high hormone levels can interfere with some methods. Laboratories can use alternative methods or blocking agents if needed.
Low-level production from the pituitary gland can occur in perimenopause and menopause. Your clinician may use clinical context or additional tests to interpret small results.
Some germ cell and placental tumors can produce this hormone. When pregnancy is excluded, persistent or rising results may prompt focused evaluation.
References